Bosentan can induce hepatic dysfunction as an adverse effectpentraxin-3 (PTX-3) is a biomarker under investigation regarding the effectiveness of estimating the risk of SSC-PAH. The gene discussed is PTX3; the disease is pulmonary arterial hypertension.